In the United States, black patients face barriers in access to many types of healthcare, leading to significant healthcare disparities. Recognition and analysis of potential barriers to access could ...

Enrollment will begin in January 2026Participants will be treated with buntanetap for 36 monthsThe study aims to enroll 500 ...

Table 1 lists various assessment tools used in the reviewed trials to measure the primary and secondary outcomes. Table 2 summarizes the primary endpoints and adverse events observed in these trials.

Deep Brain Stimulation (DBS) is an effective and safe treatment for motor symptoms in patients with movement disorders such as Parkinson’s disease. In addition to motor symptoms such as tremors, ...

Voruz, P., Pierce, J., Ahrweiller, K., Haegelen, C., Sauleau, P., Drapier, S., Drapier, D. Vérin, M., Péron, J. (2022). Motor symptom asymmetry predicts non-motor outcome and quality of life following ...

A treatment called deep brain stimulation (DBS) could extend the life of people with Parkinson's disease. Researchers at the Edward Hines, Jr. VA Hospital in Illinois found that patients who received ...

Patients who lose the use of their hands and arms after a stroke or traumatic brain injury could regain some function through deep brain stimulation (DBS), new research demonstrates. Photo by Adobe ...

Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. "This marks a new era of innovation from the ...

In 2003, Medtronic first received a humanitarian green light from the FDA to offer its deep brain stimulation implants to treat the symptoms of dystonia—the painful movement disorder that | Medtronic ...